TRIM21 and hepatocellular carcinoma: TRIM21 downregulation has been implicated in unfavourable outcomes for multiple cancer types including breast cancer, hepatocellular carcinoma, diffuse large B-cell lymphomas (DLBCL) and most recently, colitis-associated cancers (128–131).